phenyl acetate has been researched along with Apoplexy in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (35.71) | 29.6817 |
2010's | 8 (57.14) | 24.3611 |
2020's | 1 (7.14) | 2.80 |
Authors | Studies |
---|---|
De Silva, TM; Faraci, FM | 1 |
Alexander, JC; Candelario-Jalil, E; DeMars, KM; Febo, M; Yang, C | 1 |
Hung, YN; Lin, CC; Smith, R; Wang, PY | 1 |
Abbracchio, MP; Aigner, L; Bonfanti, E; Castiglioni, L; Cimino, M; Delgado-Garcia, JM; Fontana, L; Fumagalli, M; Gelosa, P; Gotti, M; Gruart, A; Lecca, D; Sironi, L; Tremoli, E | 1 |
Kastelein, JJP; Lincoff, AM; Mani, P; Menon, V; Nicholls, SJ; Nissen, SE; Puri, R; Schwartz, GG; Shao, M | 1 |
Bell, JD; Brody, L; Cash, D; Ekonomou, A; Galley, K; Rattray, I; Sahuri-Arisoylu, M; So, PW | 1 |
Garcia, R; Hu, Z; Li, Q; Olariu, A; Pei, J; Saydoff, JA; Sheng, J; Sun, GY; von Borstel, R | 1 |
Bash, D; Brennan, DM; Cavender, MA; Jukema, JW; Kastelein, JJ; Koenig, W; Lincoff, AM; Menon, V; Nambi, V; Nicholls, SJ; Nissen, SE; Rosenson, RS; Schwartz, GG; Wright, RS | 1 |
Bigazzi, R; Casani, A; Di Giorgio, A; Grazi, G; Manca Rizza, G; Migliori, M; Panichi, V; Paoletti, S; Rosati, A; Ruggeri, M; Scatena, A; Sgambato, A | 1 |
Chen, B; DeLisa, JA; Foye, PM; Nadler, SF; Stitik, TP | 1 |
Alvarez-Sabín, J; Codina, A; Molina, CA; Montaner, J; Padró, L; Quintana, M; Rovira, R | 1 |
Chan, W; Yen, HL | 1 |
Antonello, RM; Bava, A; Cazzato, G; Moretti, R; Torre, P; Ukmar, M | 1 |
Kothare, SV; Kulberg, AG; Pollack, P; Ravin, PD | 1 |
1 review(s) available for phenyl acetate and Apoplexy
Article | Year |
---|---|
Gabapentin as a drug therapy of intractable hiccup because of vascular lesion: a three-year follow up.
Topics: Acetates; Aged; Amines; Brain Stem; Cyclohexanecarboxylic Acids; Excitatory Amino Acid Antagonists; Female; Gabapentin; gamma-Aminobutyric Acid; Hiccup; Humans; Magnetic Resonance Imaging; Male; Stroke | 2004 |
3 trial(s) available for phenyl acetate and Apoplexy
Article | Year |
---|---|
Association of Initial and Serial C-Reactive Protein Levels With Adverse Cardiovascular Events and Death After Acute Coronary Syndrome: A Secondary Analysis of the VISTA-16 Trial.
Topics: Acetates; Acute Coronary Syndrome; Aged; Angina, Unstable; Australia; C-Reactive Protein; Death; Europe; Female; Humans; India; Indoles; Keto Acids; Male; Middle Aged; Myocardial Infarction; New Zealand; North America; Phospholipase A2 Inhibitors; Placebos; Risk Factors; Stroke; Treatment Outcome | 2019 |
Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial.
Topics: Acetates; Acute Coronary Syndrome; Aged; Angina, Unstable; Atherosclerosis; Atorvastatin; Double-Blind Method; Early Termination of Clinical Trials; Female; Heptanoic Acids; Humans; Indoles; Keto Acids; Male; Middle Aged; Myocardial Infarction; Phospholipases A; Phospholipases A2, Secretory; Pyrroles; Risk; Stroke; Survival Analysis; Treatment Outcome | 2014 |
Gabapentin in late-onset poststroke seizures.
Topics: Acetates; Aged; Amines; Anticonvulsants; Cyclohexanecarboxylic Acids; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Prospective Studies; Recurrence; Seizures; Stroke | 2002 |
10 other study(ies) available for phenyl acetate and Apoplexy
Article | Year |
---|---|
The DOCA-Salt Model of Hypertension for Studies of Cerebrovascular Function, Stroke, and Brain Health.
Topics: Acetates; Aldosterone; Brain; Desoxycorticosterone Acetate; Humans; Hypertension; Renin-Angiotensin System; Sodium Chloride; Stroke | 2023 |
Sustained Neurological Recovery After Stroke in Aged Rats Treated With a Novel Prostacyclin Analog.
Topics: Acetates; Age Factors; Animals; Brain Ischemia; Epoprostenol; Infarction, Middle Cerebral Artery; Male; Pyrazines; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Prostaglandin; Stroke | 2017 |
Changes in the Use of Intensive and Supportive Procedures for Patients With Stroke in Taiwan in the Last Month of Life Between 2000 and 2010.
Topics: Acetates; Adolescent; Adult; Aged; Aged, 80 and over; Brain Ischemia; Cerebral Hemorrhage; Critical Care; Female; Humans; Iodobenzenes; Life Support Care; Male; Middle Aged; Stroke; Terminal Care; Time Factors; Young Adult | 2018 |
Improvement of fiber connectivity and functional recovery after stroke by montelukast, an available and safe anti-asthmatic drug.
Topics: Acetates; Animals; Anti-Asthmatic Agents; Brain; Cyclopropanes; Infarction, Middle Cerebral Artery; Macrophages; Male; Mice; Microglia; Neuroprotective Agents; Quinolines; Stroke; Sulfides | 2019 |
Intraperitoneal delivery of acetate-encapsulated liposomal nanoparticles for neuroprotection of the penumbra in a rat model of ischemic stroke.
Topics: Acetates; Animals; Apoptosis; Brain; Brain Ischemia; Disease Models, Animal; Drug Delivery Systems; Infarction, Middle Cerebral Artery; Liposomes; Magnetic Resonance Imaging; Male; Nanoparticles; Neurogenesis; Neuroprotective Agents; Rats, Sprague-Dawley; Stroke | 2019 |
Uridine prodrug improves memory in Tg2576 and TAPP mice and reduces pathological factors associated with Alzheimer's disease in related models.
Topics: Acetates; Alzheimer Disease; Animals; Cell Line, Tumor; Cricetinae; Disease Models, Animal; Female; Gerbillinae; Humans; Male; Maze Learning; Memory; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Transgenic; Prodrugs; Stroke; Uridine | 2013 |
A pharmacoeconomic analysis of phosphate binders cost-effectiveness in the RISCAVID study.
Topics: Acetates; Aged; C-Reactive Protein; Calcium Carbonate; Calcium Compounds; Chelating Agents; Coronary Artery Disease; Cost-Benefit Analysis; Databases, Factual; Female; Humans; Kidney Failure, Chronic; Male; Markov Chains; Middle Aged; Phosphates; Prospective Studies; Quality-Adjusted Life Years; Renal Dialysis; Sevelamer; Stroke; Survival Analysis; Vitamin D | 2015 |
Central post-stroke pain syndrome: yet another use for gabapentin?
Topics: Acetates; Activities of Daily Living; Administration, Oral; Amines; Analgesics; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Pain; Stroke; Syndrome; Time Factors; Treatment Outcome | 2002 |
An East-West approach to the management of central post-stroke pain.
Topics: Acetates; Acupuncture; Aged; Amines; Amitriptyline; Analgesics, Opioid; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Combined Modality Therapy; Cyclohexanecarboxylic Acids; Excitatory Amino Acid Antagonists; Fluoxetine; Gabapentin; gamma-Aminobutyric Acid; Humans; Lamotrigine; Male; Pain; Pain Management; Physical Therapy Modalities; Stroke; Tramadol; Triazines | 2003 |
Gabapentin treatment in a child with delayed-onset hemichorea/hemiballismus.
Topics: Acetates; Adolescent; Age of Onset; Amines; Antiparkinson Agents; Basal Ganglia; Chorea; Cyclohexanecarboxylic Acids; Diagnosis, Differential; Dyskinesias; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Neural Pathways; Stroke; Treatment Outcome | 2000 |